News Focus
News Focus
Followers 85
Posts 5834
Boards Moderated 6
Alias Born 08/21/2015

Re: None

Wednesday, 08/27/2025 1:10:31 PM

Wednesday, August 27, 2025 1:10:31 PM

Post# of 800
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another Win in the Psychedelic Space?

https://www.geneonline.com/abbvie-acquires-gilgameshs-bretisilocin-for-1-2-billion-boosting-psychiatric-pipeline-and-reshaping-major-depressive-disorder-treatment/

"AbbVie now joins peers like Johnson & Johnson, Compass Pathways, MindMed, and others in investing in next-generation psychiatric therapies. This strategic pivot underscores increased industry confidence in the potential of such compounds to fill gaps left by conventional treatments."
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News